Mexico Pharmaceuticals Report - Q1 2025

Zapisane w:
Opis bibliograficzny
Wydane w:Fitch Solutions Country Industry Reports (First Quarter 2025), p. 1
Wydane:
Fitch Solutions Group Limited
Hasła przedmiotowe:
Dostęp online:Citation/Abstract
Full Text - PDF
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

MARC

LEADER 00000nab a2200000uu 4500
001 3128520398
003 UK-CbPIL
022 |a 2976-4750 
035 |a 3128520398 
045 2 |b d20250101  |b d20250331 
245 1 |a Mexico Pharmaceuticals Report - Q1 2025 
260 |b Fitch Solutions Group Limited  |c First Quarter 2025 
513 |a Industry Report 
520 3 |a Despite challenges in drug procurement and patent enforcement, Mexico's pharmaceutical industry is poised for long-term growth. This anticipated expansion is driven by the rising demand for advanced treatments for chronic diseases. As the second largest pharmaceutical market in Latin America, Mexico presents significant opportunities for companies developing innovative medications. However, relatively low per capita spending on pharmaceuticals may limit the widespread adoption of patented drugs, potentially increasing the market share of generics. Government initiatives to enhance local drug manufacturing are likely to encourage more international partnerships, especially in technological exchange. 
651 4 |a Mexico 
653 |a Pharmaceuticals 
653 |a Statistical data 
653 |a Industrywide conditions 
653 |a Market analysis 
653 |a Industry analysis 
653 |a Business forecasts 
653 |a SWOT analysis 
653 |a Pharmaceutical industry 
773 0 |t Fitch Solutions Country Industry Reports  |g (First Quarter 2025), p. 1 
786 0 |d ProQuest  |t ABI/INFORM Trade & Industry 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3128520398/abstract/embedded/6A8EOT78XXH2IG52?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3128520398/fulltextPDF/embedded/6A8EOT78XXH2IG52?source=fedsrch